|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Harvard Center for Noninvasive Brain Stimulation, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA
2 Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA
3 Department of Neurology, University of Southern California, Los Angeles, CA, USA
Correspondence to:
Correspondence to:
Felipe Fregni
330 Brookline Ave, KS 452, Boston, MA 02215, USA; ffregni{at}bidmc.harvard.edu
A systematic review and meta-analysis were conducted to quantify the efficacy of transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT) for the treatment of motor dysfunction in patients with Parkinsons disease (PD). Prospective studies which evaluated the effects of either TMS (12 studies) or ECT (five studies) on motor function in PD using the motor subscale of the Unified Parkinsons Disease Rating Scale (UPDRS) for TMS studies and any continuous measures of motor function in PD for ECT studies were included. The pooled effect size (standardised mean difference between pre-treatment versus post-treatment means) from a random effects model was 0.62 (95% confidence interval: 0.38, 0.85) for TMS treatment and 1.68 (0.79, 2.56) for ECT treatment, and from a fixed effects model was 0.59 (0.39, 0.78) for TMS treatment and 1.55 (1.07, 2.03) for ECT treatment. TMS, across applied stimulation sites and parameters, can exert a significant, albeit modest, positive effect on the motor function of patients with PD. ECT also may exert a significant effect on motor function in PD patients.
Abbreviations: DBS, deep brain stimulation; ECT, electroconvulsive therapy; PD, Parkinsons disease; rTMS, repetitive transcranial magnetic stimulation; SD, standard deviation; TMS, transcranial magnetic stimulation; UPDRS, Unified Parkinsons Disease Rating Scale; 95% CI, 95% confidence interval
Keywords: electroconvulsive therapy; meta-analysis; Parkinsons disease; transcranial magnetic stimulation
This article has been cited by other articles:
![]() |
A. Passard, N. Attal, R. Benadhira, L. Brasseur, G. Saba, P. Sichere, S. Perrot, D. Januel, and D. Bouhassira Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia Brain, October 1, 2007; 130(10): 2661 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Rossini and S. Rossi Transcranial magnetic stimulation: Diagnostic, therapeutic, and research potential Neurology, February 13, 2007; 68(7): 484 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ferreri, C. Agbokou, and S. Gauthier Recognition and management of neuropsychiatric complications in Parkinson's disease Can. Med. Assoc. J., December 5, 2006; 175(12): 1545 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fregni, C. R. Ono, C. M. Santos, F. Bermpohl, C. Buchpiguel, E. R. Barbosa, M. A. Marcolin, A. Pascual-Leone, and K. D. Valente Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD Neurology, June 13, 2006; 66(11): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., April 1, 2006; 11(2): 63 - 64. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |